Le Lézard
Classified in: Health
Subjects: NPT, SVY, WOM, BFA, BLK, DEI

Removing Barriers: Susan G. Komen® Launches Stand for H.E.R - A Health Equity Revolution Impact Report


The report outlines the organization's comprehensive approach for achieving breast health equity in the Black community.

DALLAS, Jan. 30, 2024 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, has launched the Stand for H.E.R. ? A Health Equity Revolution Breast Cancer Impact Report. This transformative report not only exposes the stark breast cancer health disparities faced by Black women in the United States, but also details Komen's concerted efforts to help dismantle these barriers and foster community relationships to create systemic change.

Susan G. Komen has launched the Stand for H.E.R. ? A Health Equity Revolution Breast Cancer Impact Report.

Breast cancer is the most prevalent cancer among Black women in the U.S., and alarming statistics reveal that Black women in the U.S. are about 40% more likely than white women to die of breast cancer. Black women are also diagnosed younger and are more likely to be diagnosed with more aggressive forms of the disease than white women. Aside from differences in tumor biology, factors such as implicit bias, substandard care and systemic racism contribute significantly to this discrepancy.

"Black women continue to face significant barriers to breast cancer care, regardless of what age they are, if they're insured or where they live," said Paula Schneider, president and CEO of Susan G. Komen. "As highlighted in our report, the Stand for H.E.R. program creates a scalable model to support marginalized populations experiencing breast health inequities. It calls on us to create a world where everyone has access to high-quality care and the same chance of survival."

Building on decades of work in health equity, Komen launched Stand for H.E.R. ? A Health Equity Revolution in 2021, a program designed to remove barriers to high-quality breast care for Black women across the U.S. using five key health equity drivers of change: Patient Support, Education, Workforce Development, Research, and Public Policy and Advocacy. The Stand for H.E.R. Impact Report showcases Komen's progress and commitment to achieving health equity for the Black community through these key drivers:

Patient Support: Bridging the Gap with Individualized Care and Financial Assistance

Education: Empowering through Knowledge and Community

Workforce Development: Shaping the Future of Healthcare Leadership

Research: Advancing Health Equity through Research

Public Policy and Advocacy: Supporting Voices for Systemic Change

While Komen's Stand for H.E.R. program has made a significant impact, the battle is far from over. To learn more about these efforts through the true stories of women who have been impacted by this work, read the Stand for H.E.R. Breast Cancer Impact Report.

For more information on Komen's efforts to close the breast cancer health equity gap for the Black community and make quality care available to all, visit www.komen.org/standforher.

About Susan G. Komen®

Susan G. Komen® is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever. Komen has an unmatched, comprehensive 360-degree approach to fighting this disease across all fronts and supporting millions of people in the U.S. and in countries worldwide. We advocate for patients, drive research breakthroughs, improve access to high-quality care, offer direct patient support and empower people with trustworthy information. Founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life, Komen remains committed to supporting those affected by breast cancer today, while tirelessly searching for tomorrow's cures. Visit komen.org or call 1-877 GO KOMEN. Connect with us on social at www.komen.org/contact-us/follow-us/.

Media Contact
[email protected] 

SOURCE Susan G. Komen


These press releases may also interest you

at 18:05
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: